| Tracy Babon, OT | |
|
157 Litchfield St, Torrington, CT 06790-6427 | |
| (203) 250-9663 | |
| (203) 699-9641 |
| Full Name | Tracy Babon |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 157 Litchfield St, Torrington, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578216834 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 5227 (Connecticut) | Primary |
| Provider Name | Legacy Healthcare Services Inc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1265178354 PECOS PAC ID: 2163339722 Enrollment ID: O20220909002018 |
News Archive
Tibotec Pharmaceuticals (Tibotec), one of the Janssen (Janssen) Pharmaceutical Companies, today will present results of the final analysis of PILLAR, a phase 2b study of the investigational hepatitis C virus (HCV) NS3/4A protease inhibitor TMC435 in treatment-naïve patients with chronic genotype 1 HCV, as part of a late-breaker oral presentation at the 62nd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in San Francisco, CA, USA.
A collaborative study from the Center for Injury Research and Prevention (CIRP) and the Center for Autism Research (CAR) at Children's Hospital of Philadelphia (CHOP) identified clear strengths and a series of specific challenges autistic adolescents experience while learning to drive.
Haemonetics Corporation announced today that it has signed a comprehensive software agreement with Blood Centers of America, Inc. ("BCA"), a cooperative of community blood centers.
In order for Rwanda to reach its HIV prevention goals, the country "need[s] to reach two million men in two years to benefit from the protective effect of [voluntary medical male circumcision] in order to achieve this as part of a comprehensive, combination HIV prevention strategy," Agnes Binagwahois, Rwanda's minister of health, writes in a Washington Post opinion piece.
In a major step to treat patients living with Myelodysplastic Syndromes (MDS), a group of diseases that affect the bone marrow and blood, Moffitt Cancer Center today announced the development of an innovative investigational biologic agent that could improve patient response and outcomes for MDS and other diseases.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tracy Babon, OT 382 S Main St, Cheshire, CT 06410-1379 Ph: (203) 250-9663 | Tracy Babon, OT 157 Litchfield St, Torrington, CT 06790-6427 Ph: (203) 250-9663 |
News Archive
Tibotec Pharmaceuticals (Tibotec), one of the Janssen (Janssen) Pharmaceutical Companies, today will present results of the final analysis of PILLAR, a phase 2b study of the investigational hepatitis C virus (HCV) NS3/4A protease inhibitor TMC435 in treatment-naïve patients with chronic genotype 1 HCV, as part of a late-breaker oral presentation at the 62nd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in San Francisco, CA, USA.
A collaborative study from the Center for Injury Research and Prevention (CIRP) and the Center for Autism Research (CAR) at Children's Hospital of Philadelphia (CHOP) identified clear strengths and a series of specific challenges autistic adolescents experience while learning to drive.
Haemonetics Corporation announced today that it has signed a comprehensive software agreement with Blood Centers of America, Inc. ("BCA"), a cooperative of community blood centers.
In order for Rwanda to reach its HIV prevention goals, the country "need[s] to reach two million men in two years to benefit from the protective effect of [voluntary medical male circumcision] in order to achieve this as part of a comprehensive, combination HIV prevention strategy," Agnes Binagwahois, Rwanda's minister of health, writes in a Washington Post opinion piece.
In a major step to treat patients living with Myelodysplastic Syndromes (MDS), a group of diseases that affect the bone marrow and blood, Moffitt Cancer Center today announced the development of an innovative investigational biologic agent that could improve patient response and outcomes for MDS and other diseases.
› Verified 9 days ago
Mrs. Melissa S Picard, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 245 Alvord Park Road, Suite 2, Torrington, CT 06790 Phone: 860-496-9851 Fax: 860-482-4047 | |
Allison Nicole Dube, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 61 Commercial Blvd, Torrington, CT 06790 Phone: 860-673-0145 | |
Marisa Ann Concilio, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 245 Alvord Park Rd Ste A2, Torrington, CT 06790 Phone: 860-482-8539 Fax: 860-482-0258 | |
Megan Deacon, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 245 Alvord Park Rd Ste A2, Torrington, CT 06790 Phone: 860-482-8539 Fax: 860-482-0258 | |
Meredith Whiting, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 215 Forest St, Torrington, CT 06790 Phone: 860-482-8554 | |
Ariel K Cerruto, Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 245 Alvord Park Rd, Torrington, CT 06790 Phone: 860-482-8539 | |
Angela C Coleman, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 157 Litchfield St, Torrington, CT 06790 Phone: 860-489-1328 Fax: 860-489-4761 |